## Laboratory Diagnosis and Antibiotic Susceptibility of S. pneumoniae ### Clinical Scenario The patient presents with community-acquired pneumonia (CAP) with classic features: fever, productive cough, pleuritic chest pain, and lobar consolidation. Blood culture isolation of gram-positive catalase-negative diplococci is consistent with S. pneumoniae. ### Correct Statements (Options 0–2) **Key Point:** Identification of S. pneumoniae relies on a combination of morphological and biochemical tests. #### Option 0: Optochin and Bile Solubility (Correct) | Test | S. pneumoniae | S. viridans | Interpretation | | --- | --- | --- | --- | | **Optochin (ethylhydrocupreine) susceptibility** | Susceptible (inhibition zone) | Resistant | Pneumococcus inhibited; viridans grows | | **Bile solubility** | Soluble (colonies dissolve) | Insoluble | Pneumococcus lyses in bile; viridans remains | **High-Yield:** Optochin + bile solubility = S. pneumoniae. This is a classic NEET PG question pattern. #### Option 1: Penicillin Resistance Mechanism (Correct) **Clinical Pearl:** S. pneumoniae resistance to beta-lactams is NOT due to beta-lactamase production (unlike *Staphylococcus aureus*). Instead, it results from **mosaic mutations** that alter penicillin-binding proteins (PBPs). 1. Mosaic PBPs have reduced affinity for beta-lactams 2. Multiple PBP mutations accumulate (horizontal gene transfer from commensal streptococci) 3. Leads to intermediate (PNSP) or high-level (PRSP) penicillin resistance 4. Resistance is **not inducible** — it is constitutive #### Option 2: Colony Morphology (Correct) **Key Point:** S. pneumoniae is alpha-hemolytic (partial hemolysis), producing a greenish discoloration on blood agar due to conversion of hemoglobin to methemoglobin. This distinguishes it from beta-hemolytic streptococci (GAS, GBS). ### Why Cephalosporin Resistance is NOT Predictable from Penicillin Results (Option 3 — THE ANSWER) **Warning:** This is a critical clinical trap. **Penicillin susceptibility does NOT reliably predict cephalosporin susceptibility in S. pneumoniae.** **Reason:** Cephalosporins (especially 3rd-generation like ceftriaxone) have different PBP-binding affinities than penicillin. A strain with intermediate penicillin resistance may still be susceptible to high-dose cephalosporins, OR it may show reduced cephalosporin susceptibility. **Clinical Pearl:** The EUCAST and CLSI guidelines recommend **separate testing** of cephalosporin susceptibility (e.g., ceftriaxone, cefotaxime) even if penicillin results are known. This is especially important for meningitis, where high-dose cephalosporin penetration into CSF is critical. **Mnemonic: PBP-Mosaics are Unpredictable** — Penicillin-Binding Protein mutations create resistance patterns that do NOT cross-predict between different beta-lactams. ### Treatment Implications - **Penicillin-susceptible:** Penicillin G or amoxicillin (CAP) - **Intermediate PNSP:** High-dose penicillin or 3rd-generation cephalosporin - **PRSP:** Cephalosporin (for CAP) or vancomycin (for meningitis) - **Cephalosporin-resistant:** Vancomycin ± rifampin (meningitis); fluoroquinolone (CAP)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.